( ( ( Commercial Advantages ) ( ( This treatment ) ( should ( ( have ( ( very low ) toxicity ) ) ( since ( ( doses ( of 5uM ) ) ( ( ( kill ( ( theparasite and ) doses ) ) up ) ( to 100uM ) ) ) ) ) ) ) ) ( ( ( do not ) ( affect ( host cells ) ) ) . ) )
(ROOT (S (NP (NP (NNP Commercial) (NNP Advantages)) (SBAR (S (NP (DT This) (NN treatment)) (VP (MD should) (VP (VB have) (NP (ADJP (RB very) (JJ low)) (NN toxicity)) (SBAR (IN since) (S (NP (NP (NNS doses)) (PP (IN of) (NP (CD 5uM)))) (VP (VBP kill) (NP (NN theparasite) (CC and) (NNS doses)) (PRT (RP up)) (PP (TO to) (NP (CD 100uM))))))))))) (VP (VBP do) (RB not) (VP (VB affect) (NP (NN host) (NNS cells)))) (. .)))
Commercial Advantages This treatment should have very low toxicity since doses of 5uM kill theparasite and doses up to 100uM do not affect host cells.
(ROOT (S (NP (NP (DT The) (JJ main) (NN advantage)) (PP (IN of) (NP (NN urea)))) (VP (VBZ is) (NP (PRP$ its) (ADJP (RB very) (JJ low)) (NN toxicity))) (. .)))